The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Immuneering Corporation(NASDAQ:IMRX) 
Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.
Website: https://immuneering.com/
Founded: 2008
CEO / Co-Founder: Ben Zeskind
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Immuneering Days Payable Outstanding ttm (DPO)
Immuneering Days Receivable Outstanding ttm (DSO)
Immuneering Op Cashflow Per Share ttm
Immuneering Free Cashflow Per Share ttm
Immuneering Cash Per Share ttm
Immuneering P/S ratio ttm
Immuneering (GAAP) P/E ratio ttm
Immuneering P/B ratio ttm
No extra charts and metrics for this ticker.